225 related articles for article (PubMed ID: 11585664)
1. The RET receptor: function in development and dysfunction in congenital malformation.
Manié S; Santoro M; Fusco A; Billaud M
Trends Genet; 2001 Oct; 17(10):580-9. PubMed ID: 11585664
[TBL] [Abstract][Full Text] [Related]
2. The RET proto-oncogene induces apoptosis: a novel mechanism for Hirschsprung disease.
Bordeaux MC; Forcet C; Granger L; Corset V; Bidaud C; Billaud M; Bredesen DE; Edery P; Mehlen P
EMBO J; 2000 Aug; 19(15):4056-63. PubMed ID: 10921886
[TBL] [Abstract][Full Text] [Related]
3. Co-segregation of MEN2 and Hirschsprung's disease: the same mutation of RET with both gain and loss-of-function?
Takahashi M; Iwashita T; Santoro M; Lyonnet S; Lenoir GM; Billaud M
Hum Mutat; 1999; 13(4):331-6. PubMed ID: 10220148
[TBL] [Abstract][Full Text] [Related]
4. Glial cell line-derived neurotrophic factor differentially stimulates ret mutants associated with the multiple endocrine neoplasia type 2 syndromes and Hirschsprung's disease.
Carlomagno F; Melillo RM; Visconti R; Salvatore G; De Vita G; Lupoli G; Yu Y; Jing S; Vecchio G; Fusco A; Santoro M
Endocrinology; 1998 Aug; 139(8):3613-9. PubMed ID: 9681515
[TBL] [Abstract][Full Text] [Related]
5. Glial cell line-derived neurotrophic factor receptor alpha1 availability regulates glial cell line-derived neurotrophic factor signaling: evidence from mice carrying one or two mutated alleles.
Tomac AC; Grinberg A; Huang SP; Nosrat C; Wang Y; Borlongan C; Lin SZ; Chiang YH; Olson L; Westphal H; Hoffer BJ
Neuroscience; 2000; 95(4):1011-23. PubMed ID: 10682708
[TBL] [Abstract][Full Text] [Related]
6. The RET receptor tyrosine kinase: activation, signalling and significance in neural development and disease.
Mason I
Pharm Acta Helv; 2000 Mar; 74(2-3):261-4. PubMed ID: 10812967
[TBL] [Abstract][Full Text] [Related]
7. Germline mutations in glial cell line-derived neurotrophic factor (GDNF) and RET in a Hirschsprung disease patient.
Angrist M; Bolk S; Halushka M; Lapchak PA; Chakravarti A
Nat Genet; 1996 Nov; 14(3):341-4. PubMed ID: 8896568
[TBL] [Abstract][Full Text] [Related]
8. [Molecular basis of Hirschsprung disease].
Inoue M; Okada A
Nihon Rinsho; 1998 Jan; 56(1):249-57. PubMed ID: 9465697
[TBL] [Abstract][Full Text] [Related]
9. RET proto-oncogene: role in kidney development and molecular pathology.
Salomon R; Attie T; Amiel J; Pelet A; Niaudet P; Lyonnet S
Adv Nephrol Necker Hosp; 1998; 28():401-17. PubMed ID: 9890001
[No Abstract] [Full Text] [Related]
10. Germline mutations of the RET ligand GDNF are not sufficient to cause Hirschsprung disease.
Salomon R; Attié T; Pelet A; Bidaud C; Eng C; Amiel J; Sarnacki S; Goulet O; Ricour C; Nihoul-Fékété C; Munnich A; Lyonnet S
Nat Genet; 1996 Nov; 14(3):345-7. PubMed ID: 8896569
[TBL] [Abstract][Full Text] [Related]
11. Two distinct mutations of the RET receptor causing Hirschsprung's disease impair the binding of signalling effectors to a multifunctional docking site.
Geneste O; Bidaud C; De Vita G; Hofstra RM; Tartare-Deckert S; Buys CH; Lenoir GM; Santoro M; Billaud M
Hum Mol Genet; 1999 Oct; 8(11):1989-99. PubMed ID: 10484767
[TBL] [Abstract][Full Text] [Related]
12. Japanese patients with sporadic Hirschsprung: mutation analysis of the receptor tyrosine kinase proto-oncogene, endothelin-B receptor, endothelin-3, glial cell line-derived neurotrophic factor and neurturin genes: a comparison with similar studies.
Sakai T; Nirasawa Y; Itoh Y; Wakizaka A
Eur J Pediatr; 2000 Mar; 159(3):160-7. PubMed ID: 10664228
[TBL] [Abstract][Full Text] [Related]
13. Mutation analysis of glial cell line-derived neurotrophic factor, a ligand for an RET/coreceptor complex, in multiple endocrine neoplasia type 2 and sporadic neuroendocrine tumors.
Marsh DJ; Zheng Z; Arnold A; Andrew SD; Learoyd D; Frilling A; Komminoth P; Neumann HP; Ponder BA; Rollins BJ; Shapiro GI; Robinson BG; Mulligan LM; Eng C
J Clin Endocrinol Metab; 1997 Sep; 82(9):3025-8. PubMed ID: 9284737
[TBL] [Abstract][Full Text] [Related]
14. The GDNF-RET signalling partnership.
Robertson K; Mason I
Trends Genet; 1997 Jan; 13(1):1-3. PubMed ID: 9009838
[No Abstract] [Full Text] [Related]
15. The sensitivity of activated Cys Ret mutants to glial cell line-derived neurotrophic factor is mandatory to rescue neuroectodermic cells from apoptosis.
Mograbi B; Bocciardi R; Bourget I; Juhel T; Farahi-Far D; Romeo G; Ceccherini I; Rossi B
Mol Cell Biol; 2001 Oct; 21(20):6719-30. PubMed ID: 11564857
[TBL] [Abstract][Full Text] [Related]
16. RET mutations in human disease.
Pasini B; Ceccherini I; Romeo G
Trends Genet; 1996 Apr; 12(4):138-44. PubMed ID: 8901418
[TBL] [Abstract][Full Text] [Related]
17. RET oncogene.
Mak YF; Ponder BA
Curr Opin Genet Dev; 1996 Feb; 6(1):82-6. PubMed ID: 8791480
[TBL] [Abstract][Full Text] [Related]
18. Defects in the kidney and enteric nervous system of mice lacking the tyrosine kinase receptor Ret.
Schuchardt A; D'Agati V; Larsson-Blomberg L; Costantini F; Pachnis V
Nature; 1994 Jan; 367(6461):380-3. PubMed ID: 8114940
[TBL] [Abstract][Full Text] [Related]
19. Mechanisms of development of multiple endocrine neoplasia type 2 and Hirschsprung's disease by ret mutations.
Takahashi M; Asai N; Iwashita T; Murakami H; Ito S
Recent Results Cancer Res; 1998; 154():229-36. PubMed ID: 10027003
[TBL] [Abstract][Full Text] [Related]
20. De novo mutation of GDNF, ligand for the RET/GDNFR-alpha receptor complex, in Hirschsprung disease.
Ivanchuk SM; Myers SM; Eng C; Mulligan LM
Hum Mol Genet; 1996 Dec; 5(12):2023-6. PubMed ID: 8968758
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]